Cyproheptadine as an appetite stimulant in children. Is it safe?
DOI:
https://doi.org/10.51798/sijis.v4iSI1.705Keywords:
cyproheptadine; child development; appetite; weight gainAbstract
Background: Cyproheptadine as an appetite stimulant in children. Is it safe? This drug has been used to increase appetite in pediatric patients, regardless of their sex or the presence of pathological conditions. The effectiveness of this drug in terms of weight gain and growth is still a matter of interest. due to the diversity of conclusions regarding its mechanism of action and therapeutic results. Methods: This bibliographic review of the scientific literature focused on research in order to obtain results around scientific articles related to the use of cyproheptadine as an appetite stimulant in pediatric patients. Results: all the articles analyzed concluded that cyproheptadine is an effective medication for weight gain in pediatric patients, based on appetite stimulation, totally independent of sex and the presence of pathological states. Conclusions: Cyproheptadine is a safe medication, and adequately tolerated in all pediatric patients. It is possible to measure the improvement in weight and growth indices in patients under twelve years of age, if consumption is for at least four consecutive weeks.
References
Acosta, HV, & Pirez, RC (2019). Cyproheptadine: Its action on appetite and body weight. A double blind study. Cuban Journal of Medicine, 11(5-6).https://revmedicina.sld.cu/index.php/med/article/view/248
Badihian, N., Saneian, H., Badihian, S., & Yaghini, O. (2018). Prophylactic therapy of cyclic vomiting syndrome in children: comparison of amitriptyline and cyproheptadine: a randomized clinical trial. Official journal of the American College of Gastroenterology| ACG, 113(1), 135-140.https://pubmed.ncbi.nlm.nih.gov/28719594/https://journals.lww.com/ajg/Abstract/2018/01000/Prophylactic_Therapy_of_Cyclic_Vomiting_Syndrome.23.aspx
Badr, B., & Naguy, A. (2022). Cyproheptadine: a psychopharmacological treasure trove?. CNS spectrums, 27(5), 533-535. doi:10.1017/S1092852921000250
Baweja, R., Hale, DE, & Waxmonsky, JG (2021). Impact of CNS stimulants for attention-deficit/hyperactivity disorder on growth: epidemiology and approaches to management in children and adolescents. CNS drugs, 35, 839-859.https://link.springer.com/article/10.1007/s40263-021-00841-w
Bertrand, V., Massy, N., Vegas, N., Gras, V., Chalouhi, C., Tavolacci, MP, & Abadie, V. (2021). Safety of Cyproheptadine, an Orexigenic Drug. Analysis of the French National Pharmacovigilance Data-Base and Systematic Review. Frontiers in pediatrics, 9, 712413. https://doi.org/10.3389/fped.2021.712413
Childs, DS, & Jatoi, A. (2019). A hunger for hunger: a review of palliative therapies for cancer-associated anorexia. Annals of palliative medicine, 8(1), 50.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252156/
Cogings, N., Bryant-Waugh, R., Wong, I., Ooi, K., & Hudson, LD (2019). P49 Cyproheptadine as an appetite stimulant in the treatment in feeding disorders.https://bmjpaedsopen.bmj.com/content/3/Suppl_1/A23.2.abstract
Costa, G., Góes, M., Gadelha, C., da Costa, M., & Pardal, P. (2019). Medicate and do not intoxicate: acute occurrences due to antihistamine in children. Pan-Amazônica de Saúde Magazine, 10, e201900072.https://dx.doi.org/10.5123/s2176-6223201900072
Grunert, J., van der Haak, N., La Vanda, C., Farrow, N., & Tai, A. (2021). Cyproheptadine as an appetite stimulant in children with cystic fibrosis. Clinical Nutrition ESPEN, 42, 407–409.https://doi.org/10.1016/j.clnesp.2021.01.015
Gupta, M., Gupta, N., Madabushi, J., & Madabushi, JS (2023). Off-Label Cyproheptadine in Children and Adolescents: Psychiatric Comorbidities, Interacting Variables, Safety, and Risks of Hepatotoxicity. Cureus, 15(1).https://assets.cureus.com/uploads/case_report/pdf/132485/20230212-21313-6dw6o6.pdf
Harrison, ME, Norris, ML, Robinson, A., Spettigue, W., Morrissey, M., & Isserlin, L. (2019). Use of cyproheptadine to stimulate appetite and body weight gain: A systematic review. Appetites, 137, 62-72.https://www.sciencedirect.com/science/article/abs/pii/S0195666318315083
Kadkhoda, F., Moharreri, F., Mohammadpour, AH, & Elyasi, S. (2019). Preventive effect of cyproheptadine on sleep and appetite disorders induced by methylphenidate: an exploratory randomized, double-blinded, placebo-controlled clinical trial. International Journal of Psychiatry in Clinical Practice, 23(1), 72-79.https://www.tandfonline.com/doi/abs/10.1080/13651501.2018.1509095
Kaenkumchorn, TK, & Goday, PS (2022). Poor Weight Gain. Current Treatment Options in Pediatrics, 8(4), 369-381.https://link.springer.com/article/10.1007/s40746-022-00253-y
Kazemi, SA, Khosravi, M., Fallah, R., Diaz, D., & Eftekhari, K. (2017). Evaluation of cyproheptadine hydrochloride effects on weight gain in underweight children with anorexia; A randomized clinical trial. International journal of pediatrics, 5(12), 6413–6419.https://doi.org/10.22038/ijp.2017.25604.2179
Kim, SY, Yun, JM, Lee, JW, Cho, YG, Cho, KH, Park, YG, & Cho, B. (2021). Efficacy and tolerability of cyproheptadine in poor appetite: a multicenter, randomized, double-blind, placebo-controlled study. Clinical Therapeutics, 43(10), 1757-1772.https://www.sciencedirect.com/science/article/abs/pii/S0149291821002976
Lemoine, A., Harbison, MD, Salem, J., Tounian, P., Netchine, I., & Dubern, B. (2018). Effect of cyproheptadine on weight and growth velocity in children with Silver-Russell syndrome. Journal of Pediatric Gastroenterology and Nutrition, 66(2), 306–311.https://doi.org/10.1097/MPG.0000000000001708
Lin, Y.-C., Yen, H.-R., Tsai, F.-J., Wang, C.-H., Chien, L.-C., Chen, A.-C., & Lin , R.-T. (2021). Effects of cyproheptadine on body weight gain in children with nonorganic failure to thrive in Taiwan: A hospital-based retrospective study. Plos One, 16(10), e0258731.https://doi.org/10.1371/journal.pone.0258731
Mohammadi, MR, Mostafavi, SA, Hosseinzadeh, P., Nojoumi, M., & Asadian, F. (2021). Comparing the Effects of Folic Acid and Cyproheptadine on Appetite, Weight, and ADHD Symptoms in Children with ADHD: A Randomized Clinical Trial. Journal of Iranian Medical Council.https://publish.kne-publishing.com/index.php/JIMC/article/view/8473
Country, SM (2019). 93. Efficacy and Safety of Cyproheptadine as an Appetite Stimulant in Adolescents. Journal of Adolescent Health, 64(2), S50.https://www.jahonline.org/article/S1054-139X(18)30570-6/fulltext
Razzaghy, M., Nourbakhsh, M., & Nourbakhsh, M. (2018). A novel treatment for height growth in patients with growth hormone insensitivity syndrome by cyproheptadine hydrochloride. Clinical Endocrinology, 88(6), 880–888.https://doi.org/10.1111/cen.13594
Spettigue, W., Norris, ML, Santos, A., & Obeid, N. (2018). Treatment of children and adolescents with avoidant/restrictive food intake disorder: a case series examining the feasibility of family therapy and adjunctive treatments. Journal of Eating Disorders, 6(1), 1-11.https://jeatdisord.biomedcentral.com/articles/10.1186/s40337-018-0205-3
Turcott, JG, Zatarain, ZL, Cárdenas Fernández, D., Castañares Bolaños, DT, & Arrieta, O. (2022). Appetite stimulants for patients with cancer: current evidence for clinical practice. Nutrition Reviews, 80(4), 857-873.https://academic.oup.com/nutritionreviews/article/80/4/857/6352185?login=false
Villarroya, E., Garcia, J., & Diaz, M. (2021). Nutrition in children with special needs due to chronic disease (oncology, nephrology, cardiology). Ergon.https://www.aeped.es/sites/default/files/documentos/45_nutr_neces_especiales.pdf
Waxmonsky, JG, Pelham III, WE, Campa, A., Waschbusch, DA, Li, T., Marshall, R., & Pelham Jr, WE (2020). A randomized controlled trial of interventions for growth suppression in children with attention-deficit/hyperactivity disorder treated with central nervous system stimulants. Journal of the American Academy of Child & Adolescent Psychiatry, 59(12), 1330-1341.https://www.sciencedirect.com/science/article/abs/pii/S089085671931929X
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Priscila Elizabeth Philco Toaza
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
